Skip to Content

View Additional Section Content

ESPERION CLEAR OUTCOMES: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY TO ASSESS THE EFFECTS OF BEMPEDOIC ACID (ETC-1002) ON THE OCCURRENCE OF MAJOR CARDIOVASCULAR EVENTS IN PATIENTS WITH, OR AT HIGH RISK FOR, CARDIOVASCULAR DISEASE WHO ARE STATIN INTOLERANT

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/NCT02993406?term=1002-043&rank=1

Clinical Trial Categories

  • Cardiology
Contact
Matthew G. Dreese, MS at 215-481-4193

Location

  • Abington Medical Specialists

Find a Physician
Search Our Directory

215-481-MEDI
215-481-6334

Schedule a
Test

215-481-EXAM
215-481-3926